In August 2023, the U.S. Department of Health and Human Services (HHS) formally recommended rescheduling cannabis. In a letter sent to the Drug Enforcement Agency (DEA), HHS provided findings from their review of marijuana’s scheduling status and recommended rescheduling marijuana to a Schedule III controlled substance.

Early this week, the Brookings Institution released a report titled 'Ending the U.S. government's war on medical marijuana research', which analyzes the ways in which the federal government hinders effective research, and how these policies could be changed. The federal government is stifling medical research in a rapidly transforming area of public policy that has consequences for public health and public safety. As medical marijuana becomes increasingly accessible in state-regulated, legal markets,…

Huge news broke today in the world of marijuana policy reform. Governors Christine Gregoire (D-WA) and Lincoln Chafee (I-RI) announced in a joint conference call that they had petitioned the federal government to reschedule marijuana. We can expect that this will produce headlines across the country. We can also expect that the coverage will tout this as a far more significant – and positive, from the perspective of patients – event than it actually is. Before harping on the negative, let’s appreciate…